Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Technology Scientific & Technical Instruments

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > How Does this work ?

<< Previous

Bullboard Posts

Next >>

Post by Ingiboyon Dec 07, 2023 11:29am

116 Views

Post# 35773094

How Does this work ?

Am I missing something? Nowhere did I see 82,000 shares available @ $.04 on the ask.

This Venture Exchange is total horse shite !

Recent Trades - All 4 today

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
09:52:40	V	0.04	-0.015	62,000	80 National Bank	2 RBC	K
09:52:40	V	0.04	-0.015	18,000	7 TD Sec	2 RBC	K
09:46:48	V	0.04	-0.015	1,000	7 TD Sec	79 CIBC	K
09:30:00	V	0.04	-0.015	1,000	7 TD Sec	7 TD Sec	KL